Published in Dig Dis Sci on October 05, 2014
Gastroprotective Effects of PMK-S005 against Ethanol-Induced Acute Gastric Damage in Rats. Gut Liver (2016) 0.82
Protective Effect of Peroxiredoxin 6 in Ischemia/Reperfusion-Induced Damage of Small Intestine. Dig Dis Sci (2015) 0.77
The caspase-1 inhibitor AC-YVAD-CMK attenuates acute gastric injury in mice: involvement of silencing NLRP3 inflammasome activities. Sci Rep (2016) 0.76
The Garlic Preparation as an Alternative Way for Gastroprotection: From Bench to Clinic. Gut Liver (2016) 0.75
PMK-S005 Alleviates Age-Related Gastric Acid Secretion, Inflammation, and Oxidative Status in the Rat Stomach. Gut Liver (2016) 0.75
Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology (2008) 2.25
Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology (1982) 2.14
Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut (2002) 1.74
Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat. Gut (1985) 1.58
Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol (2010) 1.51
Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci (2011) 1.43
Garlic [Allium sativum]: a review of its potential use as an anti-cancer agent. Curr Cancer Drug Targets (2003) 1.36
Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneimittelforschung (1993) 1.23
Roles of oxidative stress in stomach disorders. J Clin Biochem Nutr (2011) 1.20
15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Dig Dis Sci (2005) 1.19
Garlic: nature's protection against physiological threats. Crit Rev Food Sci Nutr (2009) 1.18
Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies. Ann Fam Med (2011) 1.16
Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse model. J Neurochem (2011) 1.15
Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial. J Gastroenterol (2007) 1.14
Bleeding peptic ulcer in the elderly: risk factors and prevention strategies. Drugs Aging (2007) 1.10
Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci (1993) 1.10
Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. Am J Physiol (1992) 1.09
The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection. Oxid Med Cell Longev (2012) 1.07
Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice. Gastroenterology (2000) 1.02
Rebamipide-promoted restoration of gastric mucosal sonic hedgehog expression after early Helicobacter pylori eradication. Digestion (2009) 1.01
Effect of aging on gastric mucosal defense mechanisms: ROS, apoptosis, angiogenesis, and sensory neurons. Am J Physiol Gastrointest Liver Physiol (2010) 1.00
Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomised controlled trial. Maturitas (2010) 0.99
Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers. Aliment Pharmacol Ther (2009) 0.99
Gastroprotective action of Cochinchina momordica seed extract is mediated by activation of CGRP and inhibition of cPLA(2)/5-LOX pathway. Dig Dis Sci (2009) 0.96
Adverse reactions and interactions with H2-receptor antagonists. Med Toxicol (1987) 0.95
Incidence and 30-day mortality of peptic ulcer bleeding in Korea. Eur J Gastroenterol Hepatol (2012) 0.95
Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol (2009) 0.93
Current perspectives in NSAID-induced gastropathy. Mediators Inflamm (2013) 0.91
Influence of aging on gastric ulcer healing activities of cimetidine and omeprazole. Eur J Pharmacol (2002) 0.90
Aging and upper gastrointestinal disorders. Best Pract Res Clin Gastroenterol (2004) 0.88
Gastroprotective effects of DA-6034, a new flavonoid derivative, in various gastric mucosal damage models. Dig Dis Sci (2007) 0.88
Gastric mucosal protection via enhancement of MUC5AC and MUC6 by geranylgeranylacetone. Dig Dis Sci (2005) 0.88
A simple method for estimation of gastric mucus and effects of antiulcerogenic agents on the decrease in mucus during water-immersion stress in rats. Arzneimittelforschung (1986) 0.87
Incidence and short-term mortality from perforated peptic ulcer in Korea: a population-based study. J Epidemiol (2012) 0.86
S-allyl cysteine prevents CCl(4)-induced acute liver injury in rats. Free Radic Res (2007) 0.85
From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century. J Physiol Pharmacol (2005) 0.85
Difficult establishment of a chronic nonsteroidal anti-inflammatory drugs induced gastric inflammation rat model due to gastric adaptation and small bowel damage. Korean J Gastroenterol (2014) 0.85
Gastroprotective activity of ethanolic root extract of Potentilla fulgens Wall. ex Hook. J Ethnopharmacol (2013) 0.84
Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils. Dig Dis Sci (1998) 0.83
Garlic and cardioprotection: insights into the molecular mechanisms. Can J Physiol Pharmacol (2013) 0.82
Nuclear factor κB-dependent anti-inflammatory effects of s-allyl cysteine and s-propyl cysteine in kidney of diabetic mice. J Agric Food Chem (2012) 0.81
The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide. Life Sci (2013) 0.80
Teprenone, an anti-ulcer agent, increases gastric mucosal mucus level via nitric oxide in rats. Jpn J Pharmacol (1998) 0.79
Rebamipide inhibits gastric cancer cell growth. Dig Dis Sci (2006) 0.78
Garlic in clinical practice: an evidence-based overview. Crit Rev Food Sci Nutr (2013) 0.78
Comparison of Indomethacin, Diclofenac and Aspirin-Induced Gastric Damage according to Age in Rats. Gut Liver (2012) 0.77
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet (2012) 6.78
Low-dose abdominal CT for evaluating suspected appendicitis. N Engl J Med (2012) 3.71
Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med (2008) 2.92
Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology (2012) 2.44
Seroprevalence of Helicobacter pylori in South Korea. Helicobacter (2007) 2.21
Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis. Am J Respir Crit Care Med (2010) 2.04
Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol (2008) 2.02
Functional and histological evidence for the targeted therapy using biocompatible polycaprolactone beads and autologous myoblasts in a dog model of fecal incontinence. Dis Colon Rectum (2015) 2.00
Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter (2011) 1.82
Hemostatic efficacy and clinical outcome of endoscopic treatment of Dieulafoy's lesions: comparison of endoscopic hemoclip placement and endoscopic band ligation. Gastrointest Endosc (2011) 1.68
The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci (2009) 1.65
Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology (2009) 1.64
[Risk factors for development and recurrence of peptic ulcer disease]. Korean J Gastroenterol (2010) 1.59
Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosage. J Gastroenterol Hepatol (2008) 1.58
Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding. Gut (2011) 1.56
Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia. J Clin Gastroenterol (2007) 1.55
Analysis of the lymphatic stream to predict sentinel nodes in gastric cancer patients. Ann Surg Oncol (2013) 1.53
Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. J Allergy Clin Immunol (2007) 1.52
Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea. J Gastroenterol Hepatol (2008) 1.52
[Assessment of factors affecting the accuracy of endoscopic ultrasonography in T2 stage gastric cancer]. Korean J Gastroenterol (2008) 1.51
Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry (2013) 1.51
Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea. Acta Haematol (2013) 1.50
Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest (2002) 1.47
Blood pressure variability and the development of early neurological deterioration following acute ischemic stroke. J Hypertens (2015) 1.47
Fusion image-based programming after subthalamic nucleus deep brain stimulation. World Neurosurg (2011) 1.45
Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Invest Radiol (2010) 1.44
[Efficacy and predictors of the virologic response to entecavir therapy in nucleoside-naive patients with chronic hepatitis B]. Korean J Hepatol (2010) 1.43
[Effects of proton pump inhibitors in asthmatics with gastroesophageal reflux disease]. Korean J Gastroenterol (2011) 1.42
Incidence and risk factors of irritable bowel syndrome in community subjects with culture-proven bacterial gastroenteritis. Korean J Gastroenterol (2012) 1.40
Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter (2012) 1.40
Increased tuberculosis burden due to demographic transition in Korea from 2001 to 2010. Tuberc Respir Dis (Seoul) (2013) 1.40
World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol (2012) 1.39
Hepatitis a in Korea: epidemiological shift and call for vaccine strategy. Intervirology (2008) 1.39
[Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx]. Korean J Hepatol (2009) 1.38
Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction. Hum Pathol (2007) 1.36
Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol (2010) 1.36
Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol (2003) 1.35
[Recent etiology and clinical features of acute viral hepatitis in a single center of Korea]. Korean J Hepatol (2007) 1.32
Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol (2003) 1.32
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer. BMC Cancer (2012) 1.31
Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol (2013) 1.31
Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood (2005) 1.31
Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol (2010) 1.28
Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. J Neurogastroenterol Motil (2013) 1.27
Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy. Ann Surg (2005) 1.26
Ordered nanowire array blue/near-UV light emitting diodes. Adv Mater (2010) 1.25
Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum Pathol (2011) 1.25
Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J Immunol (2005) 1.24
What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc (2011) 1.23
The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter (2008) 1.23
Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection. J Pathol (2009) 1.23
Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. J Gastroenterol Hepatol (2010) 1.23
Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. Antimicrob Agents Chemother (2004) 1.23
Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Ann Neurol (2013) 1.22
Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer. Clin Cancer Res (2005) 1.22
Learning curves for colonoscopy: a prospective evaluation of gastroenterology fellows at a single center. Gut Liver (2010) 1.22
Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study. J Gastroenterol Hepatol (2012) 1.21
Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J Comp Neurol (2004) 1.21
Primary tracheal tumors: review of 37 cases. J Thorac Oncol (2009) 1.21
Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis. APMIS (2003) 1.21
Obesity, insulin resistance and cancer risk. Yonsei Med J (2005) 1.20
Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis. Inflamm Bowel Dis (2006) 1.20
Clinical significance of intratumoral HER2 heterogeneity in gastric cancer. Eur J Cancer (2012) 1.19
Diagnosis of pelvic congestion syndrome using transabdominal and transvaginal sonography. AJR Am J Roentgenol (2004) 1.19
Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation. Cell Host Microbe (2012) 1.16
Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. J Antimicrob Chemother (2005) 1.16
Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea. J Clin Gastroenterol (2006) 1.15
Expression and mutational status of c-kit in thymic epithelial tumors. J Thorac Oncol (2010) 1.15
Clinical characteristics and treatment outcomes of 3 subtypes of achalasia according to the chicago classification in a tertiary institute in Korea. J Neurogastroenterol Motil (2013) 1.14
Korean red ginseng (Panax ginseng) ameliorates type 1 diabetes and restores immune cell compartments. J Ethnopharmacol (2012) 1.14
Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea. Helicobacter (2010) 1.14
The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter (2008) 1.12